Erik Hefti, PharmD, MS, Ph.D. Executive Director, Assistant Professor and Program Lead of Pharmaceutical Sciences
Erik Hefti is a clinical pharmaceutical scientist originally from Upstate New York. Dr. Hefti is the executive director of the Pharmaceutical Sciences graduate program at Harrisburg University. He is a licensed pharmacist in both New York and Pennsylvania that has extensive clinical practice experience in inpatient and telehealth spaces. He has also taught at the Foundation for Advanced Education in the Sciences (FAES) within the National Institutes of Health on behalf of Harrisburg University.
Research: His research focuses on pediatric pharmacogenomic factors impacting cardiovascular toxicity following cancer chemotherapy and genetic testing utilization to improve healthcare outcomes. His clinical focus involves optimizing pharmacotherapy in patients with genetic disorders and investigating telehealth outcomes in outpatient populations. Recent peer reviewed publications have focused on telehealth outcomes in Pennsylvania during the COVID-19 pandemic and the pharmacotherapeutic impact green tea supplementation may have.
Courses developed and/or taught at HU:
BTEC 635- Clinical Pharmacology
BTEC 625- Pharmacogenomics
PHAR 520 – Pharmacokinetics and Pharmacodynamics
PHAR 525- Drug Transport
PHAR 690 – Ethics and Trends in Pharmaceutical Sciences
BTEC 508 – Omics in Life Sciences
NURS 550 – Advanced Pathophysiology/Pharmacology and Health Assessment
BTEC 560 – Design of Experiment
GRAD 699 – Graduate Thesis
Education
BA (summa cum laude) – Biology 2009, St. John Fisher College, Rochester, NY, United States
PharmD – Doctor of Pharmacy Practice 2014, University at Buffalo, Buffalo, NY United States
Masters of Science – Pharmaceutical Science 2014, University at Buffalo, Buffalo, NY United States
PhD – Pharmaceutical Science 2017, University at Buffalo, Buffalo, NY United States
Related News
HarrisburgU professor finds benefits in tracking patients medication faithfulness via innovative, value-based pharmacy system
Erik Hefti, assistant professor and Director of the Pharmaceutical Sciences graduate program at Harrisburg University has a recently published study, An...
HU professor warns on the dangers of knock off pills
A nationwide shortage of prescription mixed amphetamine salts, more commonly referred to by their name-brand version Adderall, is leading people...
HU Study: Telehealth potentially lowered rate of hospitalization during COVID-19
Harrisburg, Pa. – A newly published study led by Harrisburg University of Science and Technology Professor Dr. Erik Hefti shows...
Alumni, professor publish paper in pharmaceutical science journal
Two Harrisburg University alumni and Pharmaceutical Sciences Professor Dr. Erik Hefti teamed to publish a peer-reviewed article in the Journal,...
HU professors discuss FDA approval of Pfizer COVID-19 vaccine
The U.S. Federal Drug Administration (FDA) gave Pfizer’s COVID vaccine full approval Monday, which most healthcare professionals hope will help...
HU professor weighs in on COVID-19 vaccine hesitancy
The Federal Drug Administration (FDA) is working to fully approve COVID-19 vaccines in hopes of encouraging more people to become...
Johnson & Johnson vaccine shelf life
The Food and Drug Administration extended the shelf life for the Johnson & Johnson single-dose vaccine, pushing back the expiration...
HU professor discusses COVID-19 vaccinations for kids with abc27
HU Pharmaceutical Sciences Professor, Dr. Erik Hefti, recently joined abc27 news to discuss the FDA’s expected decision to authorize the Pfizer COVID-19...
HU professors join Smart Talk to discuss vaccine passports
Those looking to travel to Europe anytime soon will have to prove that they have been vaccinated by producing vaccination...
